Pharma Mar (OTCMKTS:PHMMF – Get Free Report)’s stock price traded down 8.3% during trading on Tuesday. The stock traded as low as $70.70 and last traded at $70.70. 250 shares changed hands during mid-day trading, a decline of 84% from the average session volume of 1,597 shares. The stock had previously closed at $77.09.
Pharma Mar Trading Down 8.3%
The firm’s 50-day simple moving average is $92.90 and its two-hundred day simple moving average is $93.25.
About Pharma Mar
Pharma Mar, SA is a Spanish biopharmaceutical company focused on discovering, developing and commercializing innovative medicines derived from marine organisms. The company specializes primarily in oncology and maintains a research platform dedicated to identifying novel compounds with potential anticancer activity.
Its principal products include Yondelis (trabectedin), an anticancer treatment used in certain cases of advanced soft-tissue sarcoma and ovarian cancer, and Zepzelca (lurbinectedin), a therapy developed for patients with metastatic small-cell lung cancer whose disease has progressed during or after platinum-based chemotherapy.
See Also
- Five stocks we like better than Pharma Mar
- Tempus AI Surges on Earnings Beat, But Can the Rally Last?
- MicroVision Pivots: Mapping New Ground Beyond Auto
- Are the Fears Around Alphabet’s Search Slowdown Warranted?
- Streaming Success: Fox Corp Channels Tubi For Q1 Earnings Beat
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
